ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Recombinant L-asparaginase induction process for pharmaceutical application (2019)
Brumano, Larissa Pereira; Chaves, Flaviana da Silva; Pessoa Junior, Adalberto
Source: Journal of Biotechnology and Biomaterials. Conference titles: Global Congress on Biotechnology. Unidade: FCF
Subjects: PROTEÍNAS RECOMBINANTES, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUMANO, Larissa Pereira e CHAVES, Flaviana da Silva e PESSOA JUNIOR, Adalberto. Recombinant L-asparaginase induction process for pharmaceutical application. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.4172/2155-952X-C2-116. Acesso em: 03 nov. 2024. , 2019
APA
Brumano, L. P., Chaves, F. da S., & Pessoa Junior, A. (2019). Recombinant L-asparaginase induction process for pharmaceutical application. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.4172/2155-952X-C2-116
NLM
Brumano LP, Chaves F da S, Pessoa Junior A. Recombinant L-asparaginase induction process for pharmaceutical application [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 69.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116
Vancouver
Brumano LP, Chaves F da S, Pessoa Junior A. Recombinant L-asparaginase induction process for pharmaceutical application [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 69.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116
Trabalho de evento-resumo periodico
Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment (2019)
Costa-Silva, Tales Alexandre; Costa, Iris Munhoz ; Agamez-Montalvo, Gualberto Segundo; Pessoa Junior, Adalberto ; Monteiro, Gisele
Source: Journal of Biotechnology and Biomaterials. Conference titles: Global Congress on Biotechnology. Unidade: FCF
Subjects: LEUCEMIA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-SILVA, Tales Alexandre et al. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.4172/2155-952X-C2-116. Acesso em: 03 nov. 2024. , 2019
APA
Costa-Silva, T. A., Costa, I. M., Agamez-Montalvo, G. S., Pessoa Junior, A., & Monteiro, G. (2019). Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.4172/2155-952X-C2-116
NLM
Costa-Silva TA, Costa IM, Agamez-Montalvo GS, Pessoa Junior A, Monteiro G. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 58.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116
Vancouver
Costa-Silva TA, Costa IM, Agamez-Montalvo GS, Pessoa Junior A, Monteiro G. Bioprospecting and rational engineering of new L-asparaginase to present a better biopharmaceutical for blood cancer treatment [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 58.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116
Trabalho de evento-resumo periodico
Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia (2019)
Costa, Iris Munhoz ; Moura, Débora Custódio; Pessoa Junior, Adalberto ; Monteiro, Gisele
Source: Journal of Biotechnology and Biomaterials. Conference titles: Global Congress on Biotechnology. Unidade: FCF
Subjects: LEUCEMIA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Iris Munhoz et al. Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.4172/2155-952X-C2-116. Acesso em: 03 nov. 2024. , 2019
APA
Costa, I. M., Moura, D. C., Pessoa Junior, A., & Monteiro, G. (2019). Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia. Journal of Biotechnology and Biomaterials. Sunnyvale: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.4172/2155-952X-C2-116
NLM
Costa IM, Moura DC, Pessoa Junior A, Monteiro G. Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 57.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116
Vancouver
Costa IM, Moura DC, Pessoa Junior A, Monteiro G. Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia [Internet]. Journal of Biotechnology and Biomaterials. 2019 ; 9 57.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/2155-952X-C2-116

USP Schools

ReP

Filtros

Authors